Skip to main content

Table 1 Inclusion and exclusion criteria

From: The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma

Inclusion criteria

Exclusion criteria

Histologically confirmed MTC (surgical thyroidectomy or fine needle aspiration)

Unenhanced acquisition of the MRI scan (due to contraindications to gadolinium-based contrast agents, such as acute or chronic renal failure with estimated glomerular filtration rate < 30 mL/min or known hypersensitivity)

Whole-body 18F-DOPA PET/CT between 2010 and 2016

MRI contrast agent other than gadoxetic acid

Matching gadoxetic acid-enhanced liver MRI within 30 days

Unenhanced CT (due to contraindications for iodinated contrast agents, such as manifest hyperthyroidism, acute or chronic renal failure with estimated glomerular filtration rate < 30 mL/min or known hypersensitivity)

 

Missing or inconclusive histological results confirming the diagnosis of MTC